The hybrid conference titled “Exploring the Frontiers of Cancer Immunotherapy: From Models to Breakthroughs” took place on June 1 and 2 at the Josep Carreras Leukaemia Research Institute in Badalona (Barcelona, Spain). The event attracted a total 100 in-person and 80 virtual participants on the first day, and 80 in-person and 50 virtual attendees on the second day.
The conference aimed to spotlight novel experimental models that bridge laboratory discoveries on immunotherapy research with clinical breakthroughs. The meeting provided a platform to explore a diverse array of experimental models encompassing in vitro, ex vivo, and in vivo approaches, which offer unique opportunities to delve into the intricate interplay between the immune system, tumour microenvironment, and immunotherapy interventions in a controlled and clinically relevant context.
The conference featured six distinguished invited speakers, including renowned figures in the field of immunotherapy such as David Barbie and Silvia Formenti. Their expertise illuminated the latest advancements and future directions in cancer immunotherapy. Moreover, the event showcased the work of other participating researchers through nine selected abstracts for oral presentation and sixteen for poster presentation. This provided a forum for attendees to exchange insights, discuss challenges, and explore innovative strategies for advancing immunotherapy research.
Notably, 49 attendees received travel support attend the conference, underscoring IMMUNO-model’s commitment to facilitating broader participation and knowledge exchange within the scientific community.
In summary, the 1st IMMUNO-model conference served as a dynamic platform for advancing the frontiers of cancer immunotherapy, bringing together diverse perspectives and expertise to drive meaningful progress in the fight against cancer.